IT201900025063A1 - Composizioni gastroresistenti comprendi inositolo e/o estratto di gymnema sylvestre, loro composizioni farmaceutiche e nutraceutiche e loro uso - Google Patents

Composizioni gastroresistenti comprendi inositolo e/o estratto di gymnema sylvestre, loro composizioni farmaceutiche e nutraceutiche e loro uso

Info

Publication number
IT201900025063A1
IT201900025063A1 IT102019000025063A IT201900025063A IT201900025063A1 IT 201900025063 A1 IT201900025063 A1 IT 201900025063A1 IT 102019000025063 A IT102019000025063 A IT 102019000025063A IT 201900025063 A IT201900025063 A IT 201900025063A IT 201900025063 A1 IT201900025063 A1 IT 201900025063A1
Authority
IT
Italy
Prior art keywords
compositions
sylvestre
pharmaceutical
gastroresistant
nutraceutical
Prior art date
Application number
IT102019000025063A
Other languages
English (en)
Inventor
Alessandro Bottino
Original Assignee
Idi Integratori Dietetici Italiani S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idi Integratori Dietetici Italiani S R L filed Critical Idi Integratori Dietetici Italiani S R L
Priority to IT102019000025063A priority Critical patent/IT201900025063A1/it
Priority to PCT/IB2020/062180 priority patent/WO2021124244A1/en
Priority to EP20841770.9A priority patent/EP4076403A1/en
Publication of IT201900025063A1 publication Critical patent/IT201900025063A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
IT102019000025063A 2019-12-20 2019-12-20 Composizioni gastroresistenti comprendi inositolo e/o estratto di gymnema sylvestre, loro composizioni farmaceutiche e nutraceutiche e loro uso IT201900025063A1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT102019000025063A IT201900025063A1 (it) 2019-12-20 2019-12-20 Composizioni gastroresistenti comprendi inositolo e/o estratto di gymnema sylvestre, loro composizioni farmaceutiche e nutraceutiche e loro uso
PCT/IB2020/062180 WO2021124244A1 (en) 2019-12-20 2020-12-18 Gastro-resistant microparticles comprising inositol and/or gymnema sylvestre extract, pharmaceutical and nutraceutical compositions thereof and uses thereof
EP20841770.9A EP4076403A1 (en) 2019-12-20 2020-12-18 Gastro-resistant microparticles comprising inositol and/or gymnema sylvestre extract, pharmaceutical and nutraceutical compositions thereof and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102019000025063A IT201900025063A1 (it) 2019-12-20 2019-12-20 Composizioni gastroresistenti comprendi inositolo e/o estratto di gymnema sylvestre, loro composizioni farmaceutiche e nutraceutiche e loro uso

Publications (1)

Publication Number Publication Date
IT201900025063A1 true IT201900025063A1 (it) 2021-06-20

Family

ID=70295620

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102019000025063A IT201900025063A1 (it) 2019-12-20 2019-12-20 Composizioni gastroresistenti comprendi inositolo e/o estratto di gymnema sylvestre, loro composizioni farmaceutiche e nutraceutiche e loro uso

Country Status (3)

Country Link
EP (1) EP4076403A1 (it)
IT (1) IT201900025063A1 (it)
WO (1) WO2021124244A1 (it)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999047174A1 (en) * 1998-03-18 1999-09-23 Cambridge Biostability Limited Amorphous glasses for stabilising sensitive products
CN1263883A (zh) 1999-12-23 2000-08-23 华南理工大学 一种粉体肌醇的生产方法
JP2004107287A (ja) 2002-09-20 2004-04-08 Hokko Chem Ind Co Ltd シロ−イノシトールの製造方法
EP1974737A1 (en) * 2007-03-23 2008-10-01 Phyto Health Pharma B.V. Composition for the treatment of diabetes mellitus and metabolic syndrome
WO2014135956A1 (en) * 2013-03-07 2014-09-12 Laborest Italia S.P.A. Composition for use in the treatment of polycystic ovary syndrome
EP2782559B1 (en) 2011-11-22 2018-06-06 LO. LI. Pharma S.r.l. Pharmaceutical composition comprising myo-inositol and d-chiro-inositol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000026884A (ja) * 1998-07-10 2000-01-25 Nisshin Oil Mills Ltd:The 油性組成物を含有した粉末組成物
US20020136782A1 (en) * 2001-01-18 2002-09-26 Fleischner Albert M. Composition patent for solid-dosage form of weight loss product
US20030113310A1 (en) * 2001-12-17 2003-06-19 Van Laere Katrien Maria Jozefa Method for the treatment of obesity, overweight and fluctuations in blood insuline and/or glucose levels
NZ536267A (en) * 2002-04-10 2007-06-29 Fred H Miller Multi-phase, multi-compartment and multi-ingredient capsular system
JP4025578B2 (ja) * 2002-04-30 2007-12-19 株式会社カネボウ化粧品 痩身用食品

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999047174A1 (en) * 1998-03-18 1999-09-23 Cambridge Biostability Limited Amorphous glasses for stabilising sensitive products
CN1263883A (zh) 1999-12-23 2000-08-23 华南理工大学 一种粉体肌醇的生产方法
JP2004107287A (ja) 2002-09-20 2004-04-08 Hokko Chem Ind Co Ltd シロ−イノシトールの製造方法
EP1974737A1 (en) * 2007-03-23 2008-10-01 Phyto Health Pharma B.V. Composition for the treatment of diabetes mellitus and metabolic syndrome
EP2782559B1 (en) 2011-11-22 2018-06-06 LO. LI. Pharma S.r.l. Pharmaceutical composition comprising myo-inositol and d-chiro-inositol
WO2014135956A1 (en) * 2013-03-07 2014-09-12 Laborest Italia S.P.A. Composition for use in the treatment of polycystic ovary syndrome

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BASKARAN KKIZAR AHAMATH B ET AL.: "Antidiabetic effect of a leaf extract from Gymnema sylvestre in noninsulin-dependant diabetes mellitus patients", JETHNOPHARMACO!, vol. 30, 1990, pages 295 - 300
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 26936-24-3
PREUSS HGBAGCHI D ET AL.: "Effects of a natural extract of (-)-hydroxycitrc acid (HCA-SX) and a combination of HCA-SX plus niacin-bound chromium and Gymnema sylvestre extract on weight loss", DIABETES OBES METAB., vol. 6, no. 3, 2004, pages 171 - 80, XP009131654, DOI: 10.1111/j.1462-8902.2004.00328.x

Also Published As

Publication number Publication date
WO2021124244A1 (en) 2021-06-24
EP4076403A1 (en) 2022-10-26

Similar Documents

Publication Publication Date Title
IL276169A (en) Peptide YY pharmacological formulations, compositions and methods
EP3426348A4 (en) 3-DESOXY DERIVATIVE AND PHARMACEUTICAL COMPOSITIONS THEREOF
BR112015020139A2 (pt) compostos terapêuticos e usos dos mesmos
CO2019008103A2 (es) Composiciones farmacéuticas para terapia de combinación
WO2015061798A3 (en) Compositions and methods comprising yeast organisms and lipid extracts thereof
SG11202105540YA (en) 3,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the same
IL289932A (en) History of 6,3-diamino-pyridazin-3-yl, pharmaceutical preparations containing them and their use as pro-apoptotic agents
EP3894408A4 (en) TRIAZOLOPYRIDIN-3-ONE OR THEIR SALTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IL288645A (en) Conjugated saponin and vaccine or a pharmaceutical composition containing it
WO2016020210A8 (en) Factor viii formulation
EP3763213A4 (en) COMPOSITION INTENDED TO INDUCE RESISTANCE TO DAMAGE CAUSED BY A PLANT DISEASE OR TO PREVENT DAMAGE CAUSED BY A PLANT DISEASE
EP3897593A4 (en) CANNABINOID FORMULATIONS AND PHARMACEUTICAL COMPOSITIONS
IL276750A (en) Pharmaceutical compositions containing nabivolol
EP3539978A4 (en) NKX3.2 FRAGMENT AND PHARMACEUTICAL COMPOSITION WITH IT AS THE ACTIVE INGREDIENT
EP3858849A4 (en) DERIVATIVE BASED ON A COMMON STRUCTURE OF SARSASAPOGENIN FROM RHIZOME OF ANEMARRHENAE, PHARMACEUTICAL COMPOSITION AND USE
BR112018005299A2 (pt) 1,1-difeniletilenos substituídos com alquenilfenoxi, processos para sua preparação e seu uso
IT201900025063A1 (it) Composizioni gastroresistenti comprendi inositolo e/o estratto di gymnema sylvestre, loro composizioni farmaceutiche e nutraceutiche e loro uso
BR112017024126B8 (pt) Composições farmacêuticas, composto a micronizado e/ou pelo menos um sal farmaceuticamente aceitável micronizado do composto a e uso dos mesmos
EP3576728A4 (en) COMPOSITIONS AND METHODS TO INHIBIT THE RETICULON 4 INHIBITOR
EP3449254A4 (en) COMPOSITIONS, DEVICES AND METHODS FOR TESTING THE SENSITIVITY OF MORBUS CROHN
IT201700033543A1 (it) Piridil-formammidine ad attività fungicida, loro composizioni agronomiche e relativo uso
ES2540457B2 (es) Procedimiento de obtención de extractos de hojas de Corema album y su aplicación terapéutica
IT201800007580A1 (it) Composti 1,3,8-triazaspiro e loro uso come medicamenti
MX2019000977A (es) Composiciones farmacéuticas a base de curcumina y procedimientos para su fabricación.
ITUA20163037A1 (it) Formulazioni per uso nel trattamento o prevenzione di disturbi urologici